J&J, Merck and Novo invest in health data company

Johnson & Johnson, Merck and Novo Nordisk participated in a $150 million series E funding round for Verana Health, a digital health company that delivers data insights to drugmakers.

Advertisement

Verana Health will use the funds to expand its life sciences strategy across the drug life cycle and strengthen its database through partnerships with medical societies and other stakeholders, according to a Jan. 14 news release.

Verana will also enhance its artificial intelligence capabilities, focusing on how natural language processing can extract insights for unstructured EHR notes.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.